Drug That Celgene Bought For $710 Million Fails

·

·

Drug That Celgene Bought For $710 Million Fails

Celgene has pioneered a new strategy for bringing drugs to market that relies heavily on partnering with other companies. But bringing in R&D from outside doesn't always work out.
See Original Article

Fishy accounting snags owners of Sushi Samurai in West Bloomfield

State treasury officials suspected something was fishy about the tax payments made by an Orchard Lake sushi restaurant. Turns out, they were right.
See Original Article

Bloomberg's Week in Pictures

China's Xi Jinping speaks during the opening of the 19th National Congress of the Communist Party of China, protesters attend a vigil to demand the
See Original Article

Revere and Lynn offer competing bids for Amazon's new headquarters

LYNN – Two North Shore cities are competing for what could be the ultimate prize: 50,000 high paying jobs and a $5 billion investment from the world's largest e-commerce company.
See Original Article

Wealthy Families Are Winning Deals Away From Private Equity

Once regarded as novices, family offices are looking beyond stocks and bonds to pursue direct investments in companies and real estate. The most
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.